Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
Notice for tovorafenib (Ipsen Pty Ltd)
Active ingredients
tovorafenib
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
oral powder for suspension and film coated tablet
Indication
For the treatment of glioma
Therapeutic area
Oncology